Captor Therapeutics ® Investor Relations

      Investor Relations

      Resignation of a member of the Company's Supervisory Board

      Publication date: 2021-12-14
      Number: RB ESPI 33/2021

      Current Report No. 33/2021

      Date of preparation: 14 December 2021.

      Subject: Resignation of a member of the Company's Supervisory Board

      Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the "Company") informs that on 14 December 2021 it received a resignation letter from Mr. Marek Skibiński from the Supervisory Board of the Company.

      According to its content the resignation had an immediate effect.

      Mr. Marek Skibiński has not indicated any reasons for his resignation.